superselective embolization
Showing 1 - 25 of 645
Resistant Hypertension Trial (SAAE, traditional triple antihypertensive treatment)
Not yet recruiting
- Resistant Hypertension
- SAAE
- traditional triple antihypertensive treatment
- (no location specified)
Sep 20, 2022
Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral) Trial in Nanchang (superselective adrenal arterial embolization)
Enrolling by invitation
- Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
- superselective adrenal arterial embolization
-
Nanchang, Jiagxi, Chinathe Second Affiliated Hospital of Nanchang University
Jul 19, 2022
Positron-Emission Tomography Trial in Fuzhou (68Ga-Pentixafor)
Recruiting
- Positron-Emission Tomography
- 68Ga-Pentixafor
-
Fuzhou, Fujian, ChinaDepartment of Nuclear Medicine, First Affiliated Hospital of Fuj
Jul 27, 2022
Primary Aldosteronism Trial in Chengdu
Not yet recruiting
- Primary Aldosteronism
-
Chengdu, Sichuan, ChinaYaqiong Zhou
Feb 21, 2022
Hemophilia, Embolization, Hemarthrosis Trial in São Paulo (embolization with spherical microparticles embosphere)
Recruiting
- Hemophilia
- +5 more
- embolization with spherical microparticles embosphere
-
São Paulo, BrazilInstituto de Ortopedia e Traumatologia do Hospital das Clinicas
Nov 16, 2022
SAAE on Vascular Endothelial Function in PA Patients
Recruiting
- Primary Aldosteronism
- Super selective adrenal artery embolization
- Spironolactone
-
Nanchang, ChinaThe Second Affiliated Hospital of Nanchang University
Dec 12, 2022
Primary Aldosteronism Trial (Super selective adrenal artery embolization, Spironolactone)
Not yet recruiting
- Primary Aldosteronism
- Super selective adrenal artery embolization
- Spironolactone
- (no location specified)
Aug 12, 2022
Shoulder Pain, Tendinopathy, Rotator Cuff Tendinitis Trial (Embolization with Physical Therapy, Physical Therapy)
Not yet recruiting
- Shoulder Pain
- +5 more
- Embolization with Physical Therapy
- Physical Therapy
- (no location specified)
Oct 18, 2023
SCCHN, Squamous Cell Carcinoma Trial in Birmingham (Cisplatin)
Recruiting
- SCCHN
- Squamous Cell Carcinoma
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 5, 2023
Hepatocellular Carcinoma, Hepatocellular Carcinoma Non-resectable Trial in Rozzano (Radial TAE - Bland embolization with 40-100
Unknown status
- Hepatocellular Carcinoma
- Hepatocellular Carcinoma Non-resectable
- Radial TAE - Bland embolization with 40-100 Microparticles
- Transfemoral TAE - Bland embolization with 40-100 Microparticles
-
Rozzano, Lombardia, ItalyHumanitas Research Hospital
Jan 16, 2019
Acute Gastrointestinal Bleeding Trial in Shanghai (embolization)
Recruiting
- Acute Gastrointestinal Bleeding
- embolization
-
Shanghai, ChinaShanghai 10th People's Hospital
Sep 22, 2022
Cerebral AV Malformation Trial in Worldwide
Terminated
- Cerebral AV Malformation
-
Copenhagen, Denmark
- +15 more
Jul 28, 2021
Hepatocellular Carcinoma, Liver Cancer Trial in Granada (Chemoembolization with preloaded microparticles 100 micron and reflux
Recruiting
- Hepatocellular Carcinoma
- Liver Cancer
- Chemoembolization with preloaded microparticles 100 micron and reflux control microcatheter
-
Granada, SpainJuan Jose Ciampi Dopazo
Nov 26, 2020
Retinoblastoma Trial in Seoul (Nitroglycerin, Normal saline)
Recruiting
- Retinoblastoma
- Nitroglycerin
- Normal saline
-
Seoul, Korea, Republic ofJin-Tae Kim
Jun 2, 2022
Rectal Tumors Trial (procedure, drug, diagnostic test)
Not yet recruiting
- Rectal Neoplasms
- Arterial chemoembolization
- +4 more
- (no location specified)
Jun 26, 2022
Basilar Artery Occlusion Trial in France (Contact aspiration Thrombectomy, Stent retriever thrombectomy)
Not yet recruiting
- Basilar Artery Occlusion
- Contact aspiration Thrombectomy
- Stent retriever thrombectomy
-
Bordeaux, France
- +11 more
Aug 2, 2022
Glioblastoma Trial (Tislelizumab and Bevacizumab)
Not yet recruiting
- Glioblastoma
- Tislelizumab and Bevacizumab
- (no location specified)
Apr 12, 2023
Unresectable Hepatocellular Carcinoma Trial in Guangzhou (dTACE-HAIC, HAIC, dTACE-HAIC protocol)
Recruiting
- Unresectable Hepatocellular Carcinoma
- dTACE-HAIC
- +3 more
-
Guangzhou, Guangdong, Chinathe Second Affiliated Hospital of Guangzhou Medical University
Feb 22, 2022
Stroke, Acute Trial in France (stent retriever thrombectomy, contact aspiration thrombectomy)
Not yet recruiting
- Stroke, Acute
- stent retriever thrombectomy
- contact aspiration thrombectomy
-
Bordeaux, France
- +8 more
Oct 24, 2022
Bearing nsPVA Embolization for Uterine Artery Embolization
Not yet recruiting
- Uterine Fibroid
- Bearing nsPVA
- (no location specified)
Nov 22, 2023
Comparison of Efficacy in SBRT of HCC =5 cm With or Without TACE
Recruiting
- Small Hepatocellular Carcinoma
- +2 more
- transcatheter arterial chemoembolization
-
Beijing, ChinaThe Fifth Medical Center of PLA General Hospital (Beijing 302 ho
Sep 12, 2021
Hepatocellular Carcinoma Trial in New Delhi (N Acetylcysteine, Dexamethasone, Placebo)
Not yet recruiting
- Hepatocellular Carcinoma
- N Acetylcysteine
- +2 more
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences
Sep 8, 2023
High Grade Glioma, Glioma, Glioma, Malignant Trial in Phoenix (Temsirolimus)
Not yet recruiting
- High Grade Glioma
- +3 more
-
Phoenix, ArizonaSt. Joseph's Hospital and Medical Center
Mar 6, 2023
Knee Pain Trial (Embozene Color-Advanced Microspheres.)
Not yet recruiting
- Knee Pain
- Embozene Color-Advanced Microspheres.
- (no location specified)
Nov 13, 2023
Cerebral Arterio-venous Malformation Trial in Limoges (Blood sample)
Recruiting
- Cerebral Arterio-venous Malformation
- Blood sample
-
Limoges, FranceLimoges University Hospital
Dec 23, 2022